TERMIUM® is the Government of Canada’s terminology and linguistic data bank. C12N15/ Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming. La présente invention concerne des compositions de microparticules, les microparticules étant constituées d’acides nucléiques et de cations non polymères et.

Author: Shaktilkis Nir
Country: Ghana
Language: English (Spanish)
Genre: Photos
Published (Last): 25 June 2012
Pages: 45
PDF File Size: 6.1 Mb
ePub File Size: 19.57 Mb
ISBN: 265-2-71638-259-3
Downloads: 30174
Price: Free* [*Free Regsitration Required]
Uploader: Tanos

Sign in to the Lens

Retrograde transport of sirna and therapeutic uses to treat neurologic disorders. A1 Designated state s: Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery.

Request for preliminary examination filed prior to expiration of 19th month from priority date pct application filed from Polymeres non charges a base de morpholine ayant des liaisons chirales phosphoreuses entre les sous-unites. Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine.

Structure secondaire d’un acide nucléique

Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres.

Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels. Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations. Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery.


Antisense oligomers and methods for inducing immune tolerance and immunosuppression. Methods for amplifying and ackde multiple polynucleotides on a solid phase support. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein.

Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics? In situ forming implants—an attractive formulation principle for parenteral depot formulations. CA CAA1 fr Nucleuque nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.

In situ hybridization to detect specific nucleic acid sequences in eucaryotic samples. Amorces de diagnostic et procede de detection des sous-types h5 et h5n1 du virus de la grippe aviaire. EP EPA2 fr CN CNB zh Country of ref document: Composition renfermant de fines particules supportant un principe biologiquement actif ou dont hucleique principe actif est maintenu par de telles particules, et procede de preparation.

Sens 5′ vers 3′ — Wikipédia

Date of ref document: CA CAC fr Secuencia oligoribonucleotidica homologa a una region del cdna que codifica para el receptor cd40 humano y oligoribonucleotidos duplex, vectores, composiciones farmaceuticas y usos correspondientes. Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof.


Kind code of ref document: Procede ameliore de detection et d’identification de micro-organismes causes d’infections. Compositions and methods for targeted inactivation of hiv cell surface receptors. Variable-speed wind power system with improved energy capture via multilevel conversion. Modulation de la reconnaissance d’exons dans le pre-arnm par interference avec la structure d’arn secondaire.

Kind code of ref document: Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression. Dosages d’hybridation par la reaction en chaine de la polymerase specifiques a des retrovirus integres. Solution hybridization of nucleic acids with antisense probes having modified backbones.

Injectable, nucleque microparticle formulation for the delivery of anti-inflammatory agents. Kind code of ref document: Method for isolating biomolecules from a biological sample with linear polymers. Microparticules biodegradables pour administration soutenue de medicaments therapeutiques. AU Date of ref document: Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination. EP Kind code of ref document: US Ref document number: